or Try an Advanced Search...

    Her2/Neu Stocks List

    Symbol Grade Name % Change
    MRKR F Marker Therapeutics, Inc. 3.00
    BOLT F Bolt Biotherapeutics, Inc. 2.78
    ZNTL F Zentalis Pharmaceuticals, Inc. -1.30
    OLMA F Olema Pharmaceuticals, Inc. -4.72
    PBYI D Puma Biotechnology Inc -0.84
    GLSI D Greenwich LifeSciences, Inc. 1.25
    GTHX B G1 Therapeutics, Inc. 2.00
    MACK B Merrimack Pharmaceuticals, Inc. 0.10
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Breast Cancer Her2 Treatment Of Breast Cancer Biopharmaceutical Cancer Medicine Epidermal Growth Factor Receptor Antiestrogens Clinical Medicine Estrogen Estrogen Receptor Hormones Selective Estrogen Receptor Degraders Treatment Of Cancer Tyrosine Kinase Receptors Cancer Immunotherapy Cancer Treatment Drugs Fulvestrant Immunotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Her2/Neu stocks.

    Symbol Grade Name Weight
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 1.31
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.07
    CNCR D Loncar Cancer Immunotherapy ETF 1.05
    SBIO C ALPS Medical Breakthroughs ETF 0.87
    XBI D SPDR S&P Biotech ETF 0.77
    View all Her2/Neu ETFs...
    Compare ETFs
    Compare LABD to SBIO Compare LABD to XBI Compare SBIO to XBI

        Her2/Neu Stocks Recent News

        Date Stock Title
        May 8 ZNTL Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
        May 8 OLMA Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
        May 8 ZNTL Zentalis Pharmaceuticals Reports Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic ...
        May 7 ZNTL Zentalis Pharmaceuticals GAAP EPS of $0.14, revenue of $40.56M
        May 7 ZNTL Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
        May 5 PBYI Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
        May 5 PBYI Puma Biotechnology: A Story In Flux Heading Into Mid-2024
        May 4 PBYI Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 4 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 GTHX G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 PBYI Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
        May 2 PBYI Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M
        May 2 PBYI Puma Biotechnology Reports First Quarter Financial Results
        May 2 GTHX G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
        May 2 GTHX G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
        Related Industries: Biotechnology
        Related Stock Lists: Breast Cancer Her2 Treatment Of Breast Cancer Biopharmaceutical Cancer Medicine Epidermal Growth Factor Receptor Antiestrogens Clinical Medicine Estrogen Estrogen Receptor Hormones Selective Estrogen Receptor Degraders Treatment Of Cancer Tyrosine Kinase Receptors Cancer Immunotherapy Cancer Treatment Drugs Fulvestrant Immunotherapy
        Her2/Neu

        Browse All Tags